THC at the wheel: CBD flower consumer definitively acquitted

March 26, 2024, the Rennes Court of Appeal rendered a potentially landmark decision for CBD-consuming drivers. The case involved a shopkeeper from Pont-l'Abbé, in Brittany, who had his driver's license suspended for allegedly driving under the influence of narcotics after consuming CBD flowers.

The legal case and the decision

Convicted in the first instance, the Rennes Court of Appeal definitively acquitted the defendant, without the public prosecutor's office appealing to the Court of Cassation. The decision of the Court of Appeal is therefore final. According to Me Arnaud Bernard (Avocatlantic), the defendant's lawyer, this decision is unprecedented and highly anticipated by industry professionals CBD. The court emphasized that the offense of driving under the influence of drugs requires an intentional element, which was not established in this case.

For Paul Maclean, president of the Union of CBD Professionals (UPCBD), «the final decision could set a precedent. The previous decision by the Court of Cassation had judged the material element: the presence of THC in the blood was sufficient to constitute driving under the influence of narcotics. The Rennes Court of Appeal, however, adhered to intent.».

The defendant's defense relied on evidence that he had consumed products based on CBD and not substances classified as narcotics. Despite initial concerns from authorities due to a positive saliva test for cannabinoids, subsequent blood tests confirmed only the presence of inactive cannabis metabolites. It is important to note that the defendant was able to produce purchase invoices for CBD and testimonies from the store where he regularly bought the product, in support of his claim.

Implications for CBD consumers

This decision has wider implications for users of CBD and their interactions with the legal system. It first confirms the importance of establishing clear evidence of consumption CBD, especially in the Screening test scenarios drugs during traffic stops. The Court's decision also highlights the need for individuals to promptly request blood tests to prove consumption of CBD in cases of presumed driving under the influence of narcotics.

The decision of the Rennes Court of Appeal goes towards a better understanding of the fact that CBD is different from narcotics and does not produce psychotropic effects. By emphasizing the absence of intent in the defendant's actions, the court clarified the legal status of product consumption CBD In relation to driving offenses.

Legal Precedents and Future Considerations

This acquittal deviates from previous legal interpretations, particularly in cases of consumption of CBD and conduct. The fact that the decision is based on clear evidence and the absence of intent calls into question existing decisions on CBD and its legal implications, notably a decision by the Court of Cassation which caused a great stir in June 2023. According to her, the presence of THC in a legal product was materially sufficient to constitute driving under the influence of drugs.

It is important to note that the new decision was not appealed before the Court of Cassation, making it a definitive judgment in this matter. Its impact can vary depending on individual circumstances, including THC levels in tests, the timing of blood tests after cessation, and the availability of purchase records for products derived from CBD.

The CBD and its products continuing to gain popularity, the representative associations in the sector have long been requesting to evolve the legal framework for CBD, particularly concerning driving, by balancing consumer rights with public health and safety considerations.